Literature DB >> 7876247

The vitamin D receptor interacts with general transcription factor IIB.

P N MacDonald1, D R Sherman, D R Dowd, S C Jefcoat, R K DeLisle.   

Abstract

The vitamin D receptor (VDR) heterodimerizes with retinoid X receptors (RXR) on many vitamin D-responsive promoter elements, suggesting that this complex is the active factor in vitamin D-mediated transcription. However, the mechanism of transcriptional regulation following VDR-RXR binding to DNA is not well characterized. Using a yeast two-hybrid protein interaction assay, we demonstrate that VDR forms specific protein: protein contacts with the basal transcription factor TFIIB. Deletion analysis indicated that the carboxyl-terminal ligand binding domain of VDR interacted with a 43-residue amino-terminal domain in TFIIB. The interaction with TFIIB showed selectivity for the ligand binding domain of VDR as similar regions of RXR alpha or of retinoic acid receptor alpha did not couple with TFIIB. Binding assays with purified proteins showed a direct interaction between VDR and TFIIB in vitro. These data suggest a mechanism for VDR-dependent transcription in which protein contacts between VDR and TFIIB may impart regulatory information to the transcription preinitiation complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876247     DOI: 10.1074/jbc.270.9.4748

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4.

Authors:  S Malik; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 3.  Nuclear microenvironments support physiological control of gene expression.

Authors:  Gary S Stein; Jane B Lian; Martin Montecino; Janet L Stein; André J van Wijnen; Amjad Javed; Jitesh Pratap; Je Choi; S Kaleem Zaidi; Soraya Gutierrez; Kimberly Harrington; Jiali Shen; Daniel Young; Shirwin Pockwinse
Journal:  Chromosome Res       Date:  2003       Impact factor: 5.239

4.  Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR.

Authors:  M Downes; L J Burke; G E Muscat
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

5.  Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states.

Authors:  I G Schulman; H Juguilon; R M Evans
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  Mutational analysis of the D1/E1 core helices and the conserved N-terminal region of yeast transcription factor IIB (TFIIB): identification of an N-terminal mutant that stabilizes TATA-binding protein-TFIIB-DNA complexes.

Authors:  C S Bangur; T S Pardee; A S Ponticelli
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

Review 7.  Tissue specific and vitamin D responsive gene expression in bone.

Authors:  C White; E Gardiner; J Eisman
Journal:  Mol Biol Rep       Date:  1998-01       Impact factor: 2.316

8.  TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex.

Authors:  H Heller; E Bengal
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

9.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets.

Authors:  David Feldman; Peter J Malloy
Journal:  Bonekey Rep       Date:  2014-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.